Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,875.00p
   
  • Change Today:
    -95.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 2,909
  • Market Cap: £150.21m

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £8,541,280
Ian James Nicholson 13,000 £373,750
Bruce Hiscock 1,236 £35,535

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £150,065,110
Castlefield Fund Partners Limited 985,000 £28,318,750
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £25,443,750
Gresham House Asset Management Limited 627,782 £18,048,732
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £17,810,625
Miton Group plc 508,135 £14,608,881
The Diverse Income Trust plc 302,300 £8,691,125
Schroders plc 284,795 £8,187,856
Wasatch Advisors, Inc. 265,000 £7,618,750
Canaccord Genuity Group Inc 259,940 £7,473,275
Adrian Williams 253,372 £7,284,445

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,875.00p
Change Today -95.00p
% Change -3.20 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 2,909
Shares Issued 5.22m
Market Cap £150.21m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Price Trend
59.75% below the market average59.75% below the market average59.75% below the market average59.75% below the market average59.75% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Income
37.24% above the market average37.24% above the market average37.24% above the market average37.24% above the market average37.24% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 28-May-2025

Time Volume / Share Price
10:00 130 @ 2,810.00p
09:43 500 @ 2,850.00p
09:22 333 @ 2,850.00p
09:12 701 @ 2,850.00p
09:06 176 @ 2,810.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page